Advanced Hepatocellular Carcinoma (HCC) Clinical Trials in Guangzhou, Guangdong

HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma